ABHD12 knockdown suppresses breast cancer cell proliferation, migration and invasion

12Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Alpha/beta-hydrolase domain containing 12 (ABHD12) is a serine hydrolase that regulates immunological and neurological mechanisms. This study aimed to elucidate the oncogenic effect of ABHD12 on human breast cancer. Materials and Methods: ABHD12 expression was confirmed in breast cancer tissues and breast cancer cell lines by immunohistochemistry and quantitative RT-PCR. To determine the role of ABHD12, ABHD12 siRNA-suppressed breast cancer cells (MCF7 and MDA-MB-231 cells) were investigated for cell proliferation, migration, and invasion capabilities using MTT assays, EdU assays, colony formation assays, and Boyden chamber assays. Results: Immunohistochemical staining showed a higher ABHD12 expression in breast cancer tissues than in normal tissues. Additionally, ABHD12 knockdown was found to inhibit cell growth, proliferation, migration, and invasion in breast cancer cells. Conclusion: ABHD12 plays a crucial role in cell proliferation, migration, and invasion of breast cancer cells.

Cite

CITATION STYLE

APA

Jun, S., Kim, S. W., Lim, J. Y., & Park, S. J. (2020). ABHD12 knockdown suppresses breast cancer cell proliferation, migration and invasion. Anticancer Research, 40(5), 2601–2611. https://doi.org/10.21873/anticanres.14231

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free